MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitsuhashi, M.
Right arrow Articles by Payan, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitsuhashi, M.
Right arrow Articles by Payan, D. G.

Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation

M Mitsuhashi and DG Payan

Howard Hughes Medical Institute, University of California Medical Center, San Francisco 94143.

During the cellular differentiation of the cultured smooth muscle cells, BC3H1, the Kd and the number of binding sites for [3H]- pyrilamine were decreased transiently from 276 nM to 46.5 nM and from 13.3 x 10(6)/cell to 2 x 10(6) cell, respectively. Concanavalin A (Con- A), wheat germ agglutinin, and lentil lectin inhibited [3H]pyrilamine binding to differentiated BC3H1 cells but not to undifferentiated cells. The [3H]pyrilamine binding activity of digitonin-solubilized membranes from differentiated cells was successively recovered from Con- A agarose affinity chromatography but not from undifferentiated cell membranes. The glycosylation inhibitors tunicamycin and swainsonine inhibited the expression of high affinity pyrilamine binding sites during BC3H1 cell differentiation. The molecular weight of high affinity [3H]pyrilamine binding sites on differentiated cells were approximately 68,000 as analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis, which after treatment with N- glycanase was shifted to 40,000, a molecular weight similar to that of low affinity [3H]pyrilamine binding sites on undifferentiated cells. These data suggest that one element contributing to H1-receptor heterogeneity is receptor-N-glycosylation.

Volume 35, Issue 3, pp. 311-318, 03/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
R. Seifert, K. Wenzel-Seifert, T. Burckstummer, H. H. Pertz, W. Schunack, S. Dove, A. Buschauer, and S. Elz
Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1104 - 1115.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics